Hematology News

Luspatercept appeared safe and effective at improving anemia among adults with nontransfusion-dependent beta-thalassemia, according to study results presented during the European Hematology Association 2021 Virtual Congress.

World Sickle Cell Day is observed each year on June 19.

Patients with cancer have a five- to sevenfold increased risk for venous thromboembolism compared with patients without cancer, and chemotherapy increases the risk by 6.5-fold.

The FDA approved avapritinib for treatment of adults with advanced systemic mastocytosis.

The FDA lifted the clinical holds on four studies designed to evaluate two gene therapies for hematologic conditions.

The FDA approved ravulizumab-cwvz injection to treat children aged 1 month and older with paroxysmal nocturnal hemoglobinuria.

The FDA granted priority review to pacritinib for treatment of patients with myelofibrosis with severe thrombocytopenia, according to the agent’s manufacturer.

Pregnant women with sickle cell disease who had poor baseline gestational pulmonary function had significantly greater risk for fetal death, according to study results published in American Journal of Hematology.

Three patients with sickle cell disease who received the investigational gene therapy ARU-1801 achieved and maintained normal hemoglobin levels, according to early results of a phase 1/phase 2 trial.

The FDA approved pegcetacoplan for treatment of certain adults with paroxysmal nocturnal hemoglobinuria, according to the agent’s manufacturer.